{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:34:44Z","timestamp":1792172084321,"version":"4.4.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/wad.0b013e318266c6c3","type":"journal-article","created":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T07:42:06Z","timestamp":1344325326000},"page":"109-115","source":"Crossref","is-referenced-by-count":5,"title":["The APOE \u03b54 Allele Is Associated With Increased Frontally Mediated Neurobehavioral Symptoms in Amnestic MCI"],"prefix":"10.1097","volume":"27","author":[{"given":"Ania E.","family":"Mikos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Piryatinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Tremont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Malloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210128","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimers disease in late onset families.","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"R2-3-20210128","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/jama.1995.03520400044042","article-title":"Apolipoprotein E status as a predictor of the development of Alzheimers disease in memory-impaired individuals.","volume":"273","author":"Petersen","year":"1995","journal-title":"JAMA"},{"key":"R3-3-20210128","first-page":"574","article-title":"Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.","volume":"58","author":"Tang","year":"1996","journal-title":"Am J Hum Genet"},{"key":"R4-3-20210128","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0306-4522(94)00596-W","article-title":"Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation.","volume":"66","author":"Ohm","year":"1995","journal-title":"Neuroscience"},{"key":"R5-3-20210128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of A and cognition in aging and Alzheimer disease.","volume":"69","author":"Villemagne","year":"2011","journal-title":"Ann Neurol"},{"key":"R6-3-20210128","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1212\/WNL.53.8.1825","article-title":"APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD.","volume":"53","author":"Geroldi","year":"1999","journal-title":"Neurology"},{"key":"R7-3-20210128","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jnnp.65.3.322","article-title":"Major decrease in the volume of the entorhinal cortex in patients with Alzheimers disease carrying the apolipoprotein E epsilon4 allele.","volume":"65","author":"Juottonen","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R8-3-20210128","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1176\/jnp.15.3.354","article-title":"Accelerated memory decline in Alzheimers disease with apolipoprotein epsilon4 allele.","volume":"15","author":"Hirono","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R9-3-20210128","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1212\/01.wnl.0000188871.74093.12","article-title":"APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.","volume":"65","author":"Martins","year":"2005","journal-title":"Neurology"},{"key":"R10-3-20210128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1212\/WNL.47.2.317","article-title":"Apolipoprotein E and cognitive decline in Alzheimers disease.","volume":"47","author":"Plassman","year":"1996","journal-title":"Neurology"},{"key":"R11-3-20210128","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/archneur.1996.00550040085017","article-title":"Apolipoprotein E genotype and rate of decline in probable Alzheimers disease.","volume":"53","author":"Dal Forno","year":"1996","journal-title":"Arch Neurol"},{"key":"R12-3-20210128","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.47.2.444","article-title":"Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimers disease.","volume":"47","author":"Growdon","year":"1996","journal-title":"Neurology"},{"key":"R13-3-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000093316","article-title":"Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimers disease: retrospective and prospective analysis.","volume":"22","author":"Kleiman","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R14-3-20210128","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/WNL.47.2.440","article-title":"Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimers disease.","volume":"47","author":"Kurz","year":"1996","journal-title":"Neurology"},{"key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0447.2005.00597.x","article-title":"Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimers disease.","volume":"113","author":"Monastero","year":"2006","journal-title":"Acta Psychiatr Scand"},{"key":"R16-3-20210128","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1212\/WNL.47.1.256","article-title":"A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimers disease.","volume":"47","author":"Ramachandran","year":"1996","journal-title":"Neurology"},{"key":"R17-3-20210128","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.npp.1301148","article-title":"Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimers disease.","volume":"32","author":"Zdanys","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R18-3-20210128","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0006-3223(98)00041-9","article-title":"Apolipoprotein E genotype and noncognitive symptoms in Alzheimers disease.","volume":"45","author":"Levy","year":"1999","journal-title":"Biol Psychiatry"},{"key":"R19-3-20210128","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment.","volume":"58","author":"Petersen","year":"2001","journal-title":"Arch Neurol"},{"key":"R20-3-20210128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000144072","article-title":"The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology.","volume":"26","author":"Ramakers","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R21-3-20210128","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.neurobiolaging.2007.03.004","article-title":"Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI.","volume":"29","author":"Jack","year":"2008","journal-title":"Neurobiol Aging"},{"key":"R22-3-20210128","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jalz.2009.12.003","article-title":"Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.","volume":"6","author":"Whitehair","year":"2010","journal-title":"Alzheimers Dement"},{"key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimers disease.","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R24-3-20210128","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM199603213341202","article-title":"Preclinical evidence of Alzheimers disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.","volume":"334","author":"Reiman","year":"1996","journal-title":"N Engl J Med"},{"key":"R25-3-20210128","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11682-010-9097-9","article-title":"Failing compensatory mechanisms during working memory in older apolipoprotein E-epsilon4 healthy adults.","volume":"4","author":"Filbey","year":"2010","journal-title":"Brain Imaging Behav"},{"key":"R26-3-20210128","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000113698","article-title":"Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study.","volume":"5","author":"Hamalainen","year":"2008","journal-title":"Neurodegener Dis"},{"key":"R27-3-20210128","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000161054","article-title":"Apolipoprotein E polymorphism and brain morphology in mild cognitive impairment.","volume":"26","author":"Thomann","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R28-3-20210128","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/archpsyc.65.10.1193","article-title":"Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study.","volume":"65","author":"Geda","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"R29-3-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00002093-200401000-00004","article-title":"Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms.","volume":"18","author":"Hwang","year":"2004","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"R30-3-20210128","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00019442-200303000-00013","article-title":"Apathy and executive dysfunction in mild cognitive impairment and Alzheimer disease.","volume":"11","author":"Ready","year":"2003","journal-title":"Am J Geriatr Psychiatry"},{"key":"R31-3-20210128","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1212\/01.WNL.0000144279.21502.B7","article-title":"Impact of APOE in mild cognitive impairment.","volume":"63","author":"Farlow","year":"2004","journal-title":"Neurology"},{"key":"R33-3-20210128","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/107319119900600307","article-title":"Assessing frontal lobe behavioral syndromes with the frontal lobe personality scale.","volume":"6","author":"Grace","year":"1999","journal-title":"Assessment"},{"key":"R34-3-20210128","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jalz.2007.04.374","article-title":"The Frontal Systems Behavior Scale discriminates frontotemporal dementia from Alzheimers disease.","volume":"3","author":"Malloy","year":"2007","journal-title":"Alzheimers Dement"},{"key":"R35-3-20210128","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/1073191196003003012","article-title":"Frontal behavioral syndromes in cortical and subcortical dementia.","volume":"3","author":"Paulsen","year":"1996","journal-title":"Assessment"},{"key":"R36-3-20210128","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1176\/jnp.14.3.296","article-title":"Behavioral problems as predictors of functional abilities of vascular dementia patients.","volume":"14","author":"Zawacki","year":"2002","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R37-3-20210128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome.","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch Neurol"},{"key":"R38-3-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"R40-3-20210128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1076\/clin.12.1.43.1726","article-title":"Hopkins Verbal Learning Test-Revised: normative data and analysis of inter-form and test-retest reliability.","volume":"12","author":"Benedict","year":"1998","journal-title":"Clin Neuropsychol"},{"key":"R44-3-20210128","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"R45-3-20210128","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.wnn.0000152232.47901.88","article-title":"A review of rating scales for measuring behavior change due to frontal systems damage.","volume":"18","author":"Malloy","year":"2005","journal-title":"Cogn Behav Neurol"},{"key":"R46-3-20210128","first-page":"79","article-title":"Cognitive and behavioral features discriminate between Alzheimers and Parkinsons disease.","volume":"15","author":"Cahn-Weiner","year":"2002","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"R47-3-20210128","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00019442-200311000-00014","article-title":"Frontal behavioral syndromes and functional status in probable Alzheimer disease.","volume":"11","author":"Stout","year":"2003","journal-title":"Am J Geriatr Psychiatry"},{"key":"R48-3-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-1781(02)00264-0","article-title":"Frontal Systems Behavior Scale in schizophrenia: relationships with psychiatric symptomatology, cognition and adaptive function.","volume":"113","author":"Velligan","year":"2002","journal-title":"Psychiatry Res"},{"key":"R49-3-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/JAD-2010-1352","article-title":"Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimers disease: the role of depression and apathy.","volume":"20","author":"Palmer","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"R50-3-20210128","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1159\/000210045","article-title":"Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients.","volume":"27","author":"Vicini Chilovi","year":"2009","journal-title":"Dement Geriatr Cogn Disord"}],"container-title":["Alzheimer Disease & Associated Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002093-201304000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:51:02Z","timestamp":1618278662000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002093-201304000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/wad.0b013e318266c6c3","relation":{},"ISSN":["0893-0341"],"issn-type":[{"value":"0893-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}